Track MIST and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Milestone Pharmaceuticals Inc
1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada, H4M 2X6
IPO
2019
Employees
38
Industry
Biotechnology
Sector
Healthcare
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q2 20261-1
0
Q1 20266-6
0
Q4 20254-4
0
3-quarter cumulative
11 sells0 buys
Analyst Ratings
4 analysts covering
Buy50%recommend buy
Buy
2
Hold
2
Sell
0